TeleDaaS™ Launches as Premier Provider of Dosimetry as a Service for Clinical Research Organizations

<p>TeleDaaS revolutionizes radiopharmaceutical research by delivering highly-scalable, clinical-grade dosimetry to accelerate cancer treatment breakthroughs CHICAGO, Nov. 26, 2023 (GLOBE NEWSWIRE) &#8212; TeleDaaS™, PLLC, the leading dosimetry-as-a-service provider, made its official debut today at the Radiological Society of North America’s annual meeting, #RSNA2023. TeleDaaS specializes in delivering clinical-grade, precision-based dosimetry analysis and treatment plans to clinical [&#8230;]</p>
<p>The post <a href="https://forextv.com/top-news/teledaas-launches-as-premier-provider-of-dosimetry-as-a-service-for-clinical-research-organizations/">TeleDaaS™ Launches as Premier Provider of Dosimetry as a Service for Clinical Research Organizations</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>